Profusa (PFSA) Retained Earnings (2021 - 2026)
Profusa's (PFSA) quarterly Retained Earnings came in at $136.0 million in Q1 2026, up 1051.44% year-on-year from $11.8 million in Q1 2025, and up 1.43% quarter-over-quarter from $134.1 million in Q4 2025.
Profusa (PFSA) Retained Earnings (2021 - 2026) Analysis & Trends
Profusa's Retained Earnings history runs 6 years deep, the most recent figure standing at $136.0 million for Q1 2026.
- On a quarterly basis, Retained Earnings rose 1051.44% year-over-year to $136.0 million in Q1 2026; TTM through Mar 2026 was $136.0 million, a 1051.44% increase from a year earlier, with the FY2025 full-year figure at $134.1 million, up 2231.36% from the prior year.
- Retained Earnings rose to $136.0 million in Q1 2026 per PFSA's latest filing, from $134.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at $136.0 million in Q1 2026 and bottomed at -$22.5 million in Q2 2025.
- The 5-year median for Retained Earnings is -$3.3 million (2023), against an average of $11.9 million.
- Across the five-year window, Retained Earnings tumbled 830.58% in 2023 and soared 2231.36% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$619995.0 in 2022, then plunged by 458.04% to -$3.5 million in 2023, then surged by 266.28% to $5.8 million in 2024, then surged by 2231.36% to $134.1 million in 2025, then gained by 1.43% to $136.0 million in 2026.
- Per Business Quant, the three latest PFSA Retained Earnings figures stand at $136.0 million (Q1 2026), $134.1 million (Q4 2025), and -$3.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.32 Bn |
| 10 | Profusa | 23,566.40 | -351,433.60 | - | 136.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 136.04 Mn |
| Dec 31, 2025 | 134.12 Mn |
| Sep 30, 2025 | -3.90 Mn |
| Jun 30, 2025 | -22.51 Mn |
| Mar 31, 2025 | -14.30 Mn |
| Dec 31, 2024 | 5.75 Mn |
| Sep 30, 2024 | -5.18 Mn |
| Jun 30, 2024 | -5.08 Mn |
| Mar 31, 2024 | -4.50 Mn |
| Dec 31, 2023 | -3.46 Mn |
| Sep 30, 2023 | -3.48 Mn |
| Jun 30, 2023 | -2.87 Mn |
| Mar 31, 2023 | -3.31 Mn |
| Dec 31, 2022 | -619,995.00 |
| Sep 30, 2022 | -374,375.00 |
| Jun 30, 2022 | -1.12 Mn |
| Mar 31, 2022 | -2.20 Mn |
| Dec 31, 2021 | -5.91 Mn |